Serum 25(OH)D and diabetes risk in adults with prediabetes: evidence, potential mechanisms, and implications

Clicks: 5
ID: 339634
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #451 of 457 articles by views in the journal of clinical endocrinology & metabolism

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 457 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Correcting vitamin D deficiency to reach 25-hydroxyvitamin D levels in the replete range (≥ 20 ng/mL, as defined by the National Academy of Medicine) improves insulin secretion and sensitivity. Emerging evidence indicates that vitamin D may have a more extensive role in reducing risk of type 2 diabetes in selected adults with prediabetes. Specifically, vitamin D supplementation at doses sufficient to achieve 25-hydroxyvitamin D levels ≥ 40 ng/ml appears to confer additional benefit in reducing diabetes risk in subsets of the population with prediabetes. Herein we review evidence that achieving relatively high 25-hydroxyvitamin D levels may lower risk of progression to type 2 diabetes in selected vitamin D-replete adults with prediabetes. We consider potential mechanisms by which this may occur. We also discuss the potential benefits and risks of high-dose vitamin D supplementation across subgroups defined by genetic profile, age, and the presence of additional comorbidities. These findings indicate a potential role for a precision nutrition approach with high-dose vitamin D supplementation to lower risk of type 2 diabetes in adults with prediabetes.
Reference Key
openalex_W7225857608 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal the journal of clinical endocrinology & metabolism
Year 2026
DOI
10.1210/clinem/dgag460
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.